Target intelligence / Profile preview

Charcot-Leyden crystal protein pseudogene

Molecular classification: Pseudogene, Other

Overview

Charcot-Leyden crystal protein pseudogene (ENSG00000226025) is a genomic DNA sequence closely related to the gene encoding Charcot-Leyden crystal protein (galectin-10), a major constituent of eosinophil granules and a marker of eosinophil-driven inflammation. However, this entry is classified as a pseudogene, meaning it is not expected to encode a functional protein product, and thus lacks direct biological or therapeutic relevance. The gene symbol LGALS17A is sometimes associated with this pseudogene. Pseudogenes like this one may share sequence similarity with protein-coding genes but are typically considered non-functional[2][8].

Other names: CLCP1 pseudogeneCharcot-Leyden crystal protein pseudogene 1LGALS17A pseudogene

Beyond the preview

Go deeper on Charcot-Leyden crystal protein pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Charcot-Leyden crystal protein pseudogene.

Explore the full profile